Clinical and laboratory evaluation of hospitalized patients with severe ovarian hyperstimulation syndrome

Reproductive BioMedicine Online

Volumn 6, Issue 4, 2003, Pages 448-451

  Cunha Filho, João Sabino ^a   Samama, Marise ^a   Fanchin, Renato ^a   Righini, Claudia ^a   Kadoch, Isaac Jacques ^a   Frydman, René ^a   Olivennes, François ^a  

^a HÔPITAL ANTOINE BÉCLÈRE   (France)

Author keywords

Oestradiol; Ovarian induction; Severe OHSS; Ultrasound

Indexed keywords

FOLLITROPIN; GONADOTROPIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FERTILIZATION IN VITRO; FRANCE; HORMONE BLOOD LEVEL; HOSPITALIZATION; HUMAN; INCIDENCE; INFERTILITY; LABORATORY TEST; MENSTRUAL CYCLE; OVARY HYPERSTIMULATION; RISK MANAGEMENT; TRANSVAGINAL ECHOGRAPHY;

EID: 0038575248     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1472-6483(10)62166-9     Document Type: Article

References (19)

1. Abramov Y, Elchalal U, Schenker JG. 1999 An epidemic of severe OHSS: a price we have to pay? Human Reproduction, 14, 2181-2182.
2. Albano C, Smitz J, Camus M et al. 1997 Comparison of different doses of gonadotropin-releasing hormone antagonist Cetrorelix during controlled ovarian hyperstimulation. Fertility and Sterility 67, 917-922.
3. Al-Shawaf T, Zosmer A, Hussain S et al. 2001 Prevention of severe ovarian hyperstimulation syndrome with or without ICSI and embryo transfer: a modified coasting strategy based on ultrasound for identification of high-risk patients. Human Reproduction 16, 24-30.
4. Blankstein J, Shalev J, Saadon T et al. 1987 Ovarian hyperstimulation syndrome: prediction by number and size of preovulatory ovarian follicles. Fertility and Sterility 47, 597-602.
5. Bódis J, Torok A, Tinneberg HR 1997 LH/FSH ratio as a predictor of ovarian hyperstimulation syndrome. Human Reproduction 12, 869-871.
6. Delvigne A, Demoulin A, Smitz J et al. 1993 The ovarian hyperstimulation syndrome in in-vitro fertilization: a Belgian multicentric study. Human Reproduction 8, 1353-1360.
7. Egbase PE, Al-Sharhan M, Berlingieri P et al. 2000 Serum oestradiol and progesterone concentrations during prolonged coasting in 15 women at risk of ovarian hyperstimulation syndrome following ovarian stimulation for assisted reproduction treatment. Human Reproduction 15, 2082-2086.
8. Enskog A, Henriksson M, Unander M et al. 1999 Prospective study of the clinical and laboratory parameters of patients whom ovarian hyperstimulation syndrome developed during controlled ovarian hyperstimulation for in vitro fertilization. Fertility and Sterility 71, 808-814.
9. Enskog A, Nilsson L, Brannstrom M 2000 Peripheral blood concentrations on inhibin B are elevated during gonadotrophin stimulation in patients who later develop ovarian OHSS and inhibin A concentrations are elevated after OHSS onset. Human Reproduction 15, 532-538.
10. European Orgalutran Study Group 2000 Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial. Human Reproduction 15, 1490-1498.
11. Golan A, Ron-el R, Herman A et al. 1989 Ovarian hyperstimulation syndrome: an update review. Obstetrics and Gynecology Survey 44, 430-440.
12. Kol S, Itskovitz-Eldor J 2000 Severe OHSS: yes, there is a strategy to prevent it! Human Reproduction 15, 2266-2267.
13. Ludwig M, Jelkmann W, Bauer O et al. 1999 Prediction of severe ovarian hyperstimulation syndrome by free vascular endothelial growth factor concentrations on the day of human chorionic gonadotrophin administration. Human Reproduction 14, 2437-2441.
14. Morris RS, Paulson RJ, Sauer MV et al. 1995 Predictive value of serum oestradiol concentrations and oocyte number in severe ovarian hyperstimulation syndrome. Human Reproduction 10, 811-814.
15. Olivennes F, Fanchin R, Bouchard P et al. 1996 Triggering of ovulation by a gonadotropin-releasing hormone (GnRH) agonist in patients pretreated with a GnRH antagonist. Fertility and Sterility 66, 151-153.
16. Olivennes F, Alvarez S, Bouchard P et al. 1998 The use of a GnRH antagonist (Cetrorelix) in a single dose protocol in IVF-embryo transfer: a dose finding study of 3 versus 2 mg. Human Reproduction 13, 2411-2414.
17. Pattinson HA, Hignett M, Dunphy BC et al. 1994 Outcome of thaw embryo transfer after cryopreservation of all embryos in patients at risk of ovarian hyperstimulation syndrome. Fertility and Sterility 62, 1192-1196.
18. Tsirigotis M, Hutchon S, Yazdani N et al. 1995 The value of oestradiol estimations in controlled ovarian hyperstimulation cycles. Human Reproduction 10, 972-976.
19. Whelan JG, Vlahos NF 2000 The ovarian hyperstimulation syndrome. Fertility and Sterility 73, 883-896.